[1. Ferlay J., Soerjomataram I., Ervik M., Dikshit R., Eser S., Mathers C., et al. International Agency for Research on Cancer; Lyon, France: 2013. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC Cancer Base No. 11. Available online: http://globocan.iarc.fr.]Search in Google Scholar
[2. Wentzensen N, Arbyn M, Berkhof J, Bower M, Canfell K, Einstein M, et al. Eurogin 2016 Roadmap: How HPV knowledge is changing screening practice. Int J Cancer. 2016 Dec 22. [Epub ahead of print] DOI: 10.1002/ijc.3057910.1002/ijc.3057928006858]Search in Google Scholar
[3. Castellsagué X, Díaz M, de Sanjosé S, Mu-oz N, Herrero R, Franceschi S, et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. J. Natl. Cancer Inst. 2006;98:303-315. DOI: 10.1093/jnci/djj06710.1093/jnci/djj06716507827]Search in Google Scholar
[4. Ursu RG., Onofriescu M, Nemescu D, Iancu LS. HPV prevalence and type distribution in women with or without cervical lesions in the Northeast region of Romania. Virol J. 2011;8:558. DOI: 10.1186/1743-422X-8-55810.1186/1743-422X-8-558325721222192090]Search in Google Scholar
[5. Melinte-Popescu A., Costăchescu G. Human papilloma virus infection and cervical dysplasia. Rev Med Chir Soc Med Nat Iasi. 2012;116(3):853-857.]Search in Google Scholar
[6. Feticu L., Bocşan I.S., Bondor C.I., Boboş C. Geographical distribution of human papillomavirus and their correlation with cytologic abnormalities in cervical lesions and with the age in a female population from Transylvania. Rev Med Chir Soc Med Nat Iasi. 2012;116(1):291-298.]Search in Google Scholar
[7. Voidăzan S, Morariu SH, Căpîlna M, Mărginean C, Dobreanu M. The prevalence and distribution of high risk Human Papillomavirus genotypes in patients with dysplastic lesions: a population study. Acta Medica Marisiensis 2015;61(4):314-319.10.1515/amma-2015-0107]Search in Google Scholar
[8. Pista A, de Oliveira CF, Lopes C, Cunha MJ; CLEOPATRE Portugal Study Group. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study. Int J Gynecol Cancer. 2013 Mar;23(3):500-6. DOI: 10.1097/ IGC.0b013e318280f26e10.1097/IGC.0b013e318280f26e23392401]Search in Google Scholar
[9. Hadzisejdić I, Simat M, Bosak A, Krasević M, Grahovac B. Prevalence of human pa-pillomavirus genotypes in cervical cancer and precursor lesions. Coll Antropol. 2006 Dec;30(4):879-83.]Search in Google Scholar
[10. Kietpeerakool C, Kleebkaow P, Srisomboon J. Human Papillomavirus Genotype Dis-tribution among Thai Women with High-Grade Cervical Intraepithelial Lesions and Invasive Cervical Cancer: a Literature Review. Asian Pac J Cancer Prev. 2015;16(13):5153-8. DOI: 10.7314/APJCP.2015.16.13.515310.7314/APJCP.2015.16.13.5153]Search in Google Scholar
[11. Chen W, Zhang X, Molijn A, Jenkins D, Shi JF, Quint W, et al. Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Can-cer Causes Control. 2009 Nov;20(9):1705-13. DOI: 10.1007/s10552-009-9422-z10.1007/s10552-009-9422-z19705288]Search in Google Scholar
[12. Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neo-plasia across 5 countries in Asia. Int J Gynecol Cancer. 2013 Jan;23(1):148-56. DOI: 10.1097/IGC.0b013e31827670fd10.1097/IGC.0b013e31827670fd23221730]Search in Google Scholar
[13. Denny L, Adewole I, Anorlu R, Dreyer G, Moodley M, Smith T, et al. Human papil-lomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014 Mar 15;134(6):1389-98. DOI: 10.1002/ijc.2842510.1002/ijc.2842523929250]Search in Google Scholar
[14. Ennaifer E, Salhi F, Laassili T, Fehri E, Ben Alaya N, Guizani I, et al. Type-specific Human Papillomavirus distribution in invasive squamous cervical carcinomas in Tunisia and vaccine impact. Asian Pac J Cancer Prev. 2015;16(15):6769-72. DOI: 10.7314/ APJCP.2015.16.15.676910.7314/APJCP.2015.16.15.676926434909]Search in Google Scholar
[15. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048-56. DOI: 10.1016/S1470-2045(10)70230-810.1016/S1470-2045(10)70230-8]Search in Google Scholar
[16. Giorgi Rossi P, Sideri M, Carozzi FM, Amina Vocaturo, Franco Maria Buonaguro, Maria Lina Tornesello, et al. HPV type distribution in invasive cervical cancers in Italy: pooled analysis of three large studies. Infectious Agents and Cancer. 2012;7:26. DOI: 10.1186/1750-9378-7-2610.1186/1750-9378-7-26352718123110797]Search in Google Scholar
[17. Loya A, Serrano B, Rasheed F, Tous S, Hassan M, Clavero O, et al. Human Papillo-mavirus genotype distribution in invasive cervical cancer in Pakistan. Cancers (Basel). 2016 Jul 30;8(8). pii: E72. DOI: 10.3390/cancers808007210.3390/cancers8080072499978127483322]Search in Google Scholar
[18. Siegler E, Sharir K, Lavie O, Saked-Misan P, Machulki L, Auslender R, et al. The pre-valence of HPV types in women with CIN 2-3 or cervical cancer in Haifa District, Is-rael. Minerva Ginecol. 2016 Sep 16. [Epub ahead of print]10.23736/S0026-4784.16.03980-027636902]Search in Google Scholar
[19. Anderson LA, O’Rorke MA, Wilson R, Jamison J, Gavin AT Northern Ireland HPV Working Group. HPV prevalence and type-distribution in cervical cancer and prema-lignant lesions of the cervix: A population-based study from Northern Ireland. J Med Virol. 2016 Jul;88(7):1262-70. DOI: 10.1002/jmv.2444710.1002/jmv.2444726680281]Search in Google Scholar
[20. Hammer A, Rositch A, Qeadan F, Gravitt PE, Blaakaer J. Age-specific prevalence of HPV16/18 genotypes in cervical cancer: A systematic review and meta-analysis. Int J Cancer. 2016 Jun 15;138(12):2795-803. DOI: 10.1002/ijc.29959 10.1002/ijc.2995926661889]Search in Google Scholar